Heather joined the Board of Oxford Science Enterprises in late 2021, bringing over 30 years of healthcare and biotech venture capital experience as a scientist, physician and management consultant.
She is currently Managing General Partner of Pivotal BioVenture Partners, a San Francisco based venture capital fund focused on investing in innovative therapeutics and therapeutic platforms. Prior to Pivotal, she was a Firm Partner and Managing Director at TPG Biotech.
Heather has also spent time at JP Morgan, New Enterprise as an Entrepreneur-in-Residence, and McKinsey & Co., leading the pharmaceutical and medical products consulting practice.
Heather holds a BSc in Biochemistry from the University of London, and a medical degree from the University of Oxford. She completed a post-doctoral fellowship in molecular biology at the Dana Farber Cancer Institute, Harvard University and trained in Internal Medicine at the Massachusetts General Hospital, Harvard.